Therapeutic management of hyperlipoproteinemia (a)

Constantine E Kosmas1, Andreas Sourlas2, Gordon Mallarkey3

  • 1Department of Medicine, Division of Cardiology, Montefiore Medical Center, Bronx, NY, USA.

Drugs in Context
|September 27, 2019
PubMed

Insights

Elevated lipoprotein (a) [Lp(a)] is a major cardiovascular disease risk. This review discusses current and emerging therapies, including statins and novel treatments like PCSK9 inhibitors, to manage hyperlipoproteinemia (a).

Area of Science:

  • Cardiology
  • Genetics
  • Pharmacology

Background:

  • Cardiovascular disease (CVD) remains the leading global cause of mortality.
  • Elevated plasma lipoprotein (a) [Lp(a)] is a significant, independent risk factor for CVD and calcific aortic valve stenosis.

Purpose of the Study:

  • To review and discuss current and emerging therapeutic strategies for managing hyperlipoproteinemia (a).
  • To assess the potential impact of reducing Lp(a) levels on cardiovascular risk.

Main Methods:

  • Review of current clinical and epidemiological data.
  • Analysis of existing and investigational therapeutic interventions for hyperlipoproteinemia (a).

Main Results:

  • Established therapies like aspirin, niacin, estrogens, and statins may help mild to moderate Lp(a) elevations.
  • Emerging treatments including PCSK9 inhibitors, Lp(a) apheresis, and novel antisense oligonucleotides show promise for severe cases.

Conclusions:

  • Effective management of hyperlipoproteinemia (a) is crucial for reducing cardiovascular risk.
  • A range of therapeutic options exist, from traditional medications to novel agents, offering potential benefits for patients with elevated Lp(a).

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
870
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
560
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
205
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.3K